As discussed last month, new category III codes that could impact your interventional radiology coding services are now effective as of January 1, 2022. With these codes now active, interventional radiology providers and stakeholders should be aware of the scope of changes in place for the new year. New code 0644T mentioned in last month’s insight, has a significant amount of detail for correct coding and comprehension. By knowing the rationale, staff and coders can prepare for a successful year while safeguarding compliance.

Coding Inclusion

So, what do the breast biopsy codes include? Breast biopsy codes include the following components:

  • the percutaneous biopsy
  • placement of a localization device
  • imaging of the biopsy specimen, and guidance.

Understand that guidance, localization device placement, and/or imaging of the removed specimen should not be separately coded when associated with a percutaneous biopsy.

It no longer matters whether the biopsy is performed using a rotating or vacuum-assisted device; instead, the code choice depends on the type of guidance. These codes may be used even when a localization device is not placed, or a surgical specimen is not x-rayed because the code description indicates “if performed.”

Frequently, a clip is placed at the biopsy site after a percutaneous biopsy. These clips can be seen under radiographic imaging and are placed in case other intervention is later required. The clip indicates the location of the biopsy site. Clip placement is included in the percutaneous breast biopsy codes when performed by the same physician at the same session.

Coding Rationale and Inappropriate Application

There are several types of guidance including:

  • stereotactic
  • ultrasound
  • or magnetic resonance

For each type of guidance, there is a code for first lesion and another for each additional lesion. The “each additional lesion” code would be assigned for a second lesion biopsied using the same type of guidance, whether in the same or opposite breast as the first lesion.

Understand that it is not appropriate to report an initial lesion code with modifier 50 for biopsy of bilateral lesions using the same type of guidance. Coding would be the same if a single lesion is biopsied in each breast or if two lesions in one breast are separately biopsied using the same type of guidance. If bilateral lesions or two lesions in one breast are separately biopsied using different types of guidance, assign the appropriate “first lesion” code for each.

For example, if a lesion in the right breast is biopsied using ultrasound guidance, and a separate lesion in the same breast must be biopsied under MRI guidance, you would submit codes 19083 and 19085. However, if separate lesions in the left and right breast are both biopsied using ultrasound guidance, codes 19083 and 19084 would be reported.

19081 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance
+19082 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including stereotactic guidance (List separately in addition to code for primary procedure)
19083 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance
+19084 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including ultrasound guidance (List separately in addition to code for primary procedure)
19085 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance
+19086 Biopsy, breast, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; each additional lesion, including magnetic resonance guidance (List separately in addition to code for primary procedure)
Mammographic Guidance and Aspiration Biopsy

There is no longer a code for mammographic guidance for needle placement. If a percutaneous breast biopsy is performed under mammographic guidance, the unlisted surgical code 19499 should be assigned. Code 19499 also should be reported if CT guidance is used for a percutaneous breast biopsy.

19499 Unlisted procedure, breast
Note that if a percutaneous breast biopsy is performed without imaging guidance, code 19100 would be appropriate.
19100 Biopsy of breast; percutaneous, needle core, not using imaging guidance (separate procedure)

So how is aspiration biopsy coded? Aspiration biopsy of the breast is coded using the appropriate generic FNA code (10021, 10004-10012). Note that coders sometimes have trouble deciding between an FNA and breast cyst aspiration (19000-19001). The FNA code would be assigned when the intent of the procedure was to obtain a sample of cells or fluid for diagnostic evaluation, even if the lesion was a cyst. Code 19000 is assigned if the intent was to drain a cyst, even if the aspirated material is sent to the lab for cytologic evaluation.

Explore more topics, crack through the complexity of interventional radiology, and master more coding through expert-infused tips by using our Essentials of Interventional Radiology Coding resource. Create success for 2022 and beyond.

Information source for breast biopsy statistic:

https://www.cbsnews.com/news/breast-biopsies-often-get-it-wrong/

Facebook
Twitter
LinkedIn

Bryan Nordley

Bryan Nordley is a seasoned professional writer, strategist, and researcher with over a decade’s worth of combined experience. Bryan launched his professional health writing career at the University of British Columbia’s Faculty of Medicine, one of the top 30 faculty of medicine programs in the world, working under the School of Public Health as a communications assistant. From there, he expanded his expertise and knowledge into private healthcare and podiatry before taking the role of healthcare writer at MedLearn Media. Bryan is the lead writer for the MedLearn Publishing brand previously producing both the acclaimed radiology and laboratory compliance manager newsletter products, while currently writing the compliance questions of the week which reach over 10,000 subscribers, creating the MedLearn Publishing Insights blogs and collaborating with operations and nationally renowned subject matter experts, in addition to serving as an editor for a variety of MedLearn publications along with marketing initiatives. Bryan continues to keep his pulse on the latest healthcare industry news, analyzing and reporting with strategic insight.

Related Stories

SOS: Sepsis! Let’s Fix ICD-10-CM

Let’s admit it: the International Classification of Diseases, 10th Edition, Clinical Modification (ICD-10-CM) official conventions, guidelines, and advice involving sepsis and its consequences have been

Read More

Changes in E&M Coding for 2027

The Centers for Medicare & Medicaid Services (CMS) is continuing its multi-year push toward payment accuracy, documentation integrity, and value-based care. While the most visible

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

AI, Audits, and the Future of the Revenue Cycle

Artificial intelligence is rapidly transforming healthcare revenue cycle operations, from coding and auditing to compliance and denials. Join industry leaders Pam Warren (MaineHealth) and Raemarie Jimenez (AAPC) for a live fireside chat exploring how AI is changing workflows, workforce roles, payer-provider dynamics, and compliance risk—and what organizations should be doing now to prepare.

June 17, 2026

Trending News

Featured Webcasts

Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules – Part 2

Medicare regulations are complex and even seasoned professionals struggle to apply them consistently. Due to overwhelming demand, Dr. Hirsch returns for Part 2 of Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules to answer even more of Medicare’s most misunderstood questions, covering inpatient status, observation, SNF access, Medicare Advantage denials, and more. Join Dr. Hirsch as he provides clear, referenced answers to real-world questions submitted by your peers, helping you navigate Medicare compliance with confidence and clarity.

June 18, 2026

Reengineering Utilization Management: Building an Adaptive Model for the New Payer Era

Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.

May 20, 2026

Compliance for the Inpatient Psychiatric Facility (IPF-PPS): Minimizing Federal Audit Findings by Strengthening Best Practices

Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.

April 9, 2026

Mastering MDM for Accurate Professional Fee Coding

In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.

March 31, 2026

Trending News

Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24